Cleo Diagnostics Ltd (ASX:COV)
Australia
· Delayed Price · Currency is AUD 0.4000
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 44.98 million as of June 27, 2025. Its market cap has increased by 7.69% in one year.
Market Cap
44.98M
Enterprise Value
37.66M
Revenue
210.81K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 44.98M, an increase of 75.00%. That is a compound annual growth rate of 35.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 44.98M | -1.41% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 115.46B |
| Pro Medicus | 28.94B |
| Cochlear | 19.27B |
| Sonic Healthcare | 12.56B |
| Telix Pharmaceuticals | 8.23B |
| Ramsay Health Care | 8.19B |
| Ansell | 4.35B |
| Regis Healthcare | 2.30B |